pentavac diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and haemophilus influenzae type b co
sanofi pasteur - purified diphtheria toxoid ph. eur.; purified tetanus toxoid; adsorbed purified pertussis toxoid; adsorbed purified filamentous haemagglutinin; inactivated poliomyelitis virus ph. eur; inactivated type 1 poliovirus; inactivated type 2 poliovirus; inactivated type 3 poliovirus; haemophilus influenzae type b, conjugate with tetanus protein - powder for suspension for injection - 0.5 millilitre(s) - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus
bronchin inactivated ndv, v.h. strain ?10???eid??/dose + inactivated ibv, m-41 strain?10???eid??/dose other systemic liquids
abic biological laboratories ltd - inactivated ndv, v.h. strain + inactivated ibv, m-41 strain - other systemic liquids - inactivated ndv, v.h. strain ?10???eid??/dose + inactivated ibv, m-41 strain?10???eid??/dose
tetravac, suspension for injection in prefilled syringediphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine,(adsorbed).
sanofi pasteur - purified tetanus toxoid; purified diphtheria toxoid ph. eur.; adsorbed purified pertussis toxoid; adsorbed purified filamentous haemagglutinin; inactivated poliomyelitis virus ph. eur; inactivated type 1 poliovirus; inactivated type 2 poliovirus; inactivated type 3 poliovirus - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - bacterial and viral vaccines, combined; diphtheria-pertussis-poliomyelitis-tetanus
avisan secure inactivated salmonella enteritidis ? 1/13 + inactivated salmonella typhimurium ? 1/40 parenteral ordinary vial
laboratorios hipra s.a - inactivated salmonella enteritidis pt-4 fagotype mat + inactivated salmonella typhimurium, dt-4 fagotype mat - parenteral ordinary vials - inactivated salmonella enteritidis ? 1/13 + inactivated salmonella typhimurium ? 1/40
nd+ib+vp2 inactivated, nd virus (v.h strain) ?10???eid??/dose + inactivated, ib virus (m41 strain) ?10??¹eid??/dose + ibd virus,
abic biological laboratories ltd - inactivated, newcastle disease virus (v.h strain) + inactivated, infectious bronchitis virus (m41 strain) + infectious bursal disease virus (israeli strain vp2 protein) - parenteral ordinary i m vials - inactivated, nd virus (v.h strain) ?10???eid??/dose + inactivated, ib virus (m41 strain) ?10??¹eid??/dose + ibd virus, vp2 prote
aquavac pd3 emulsion for injection for atlantic salmon
intervet ireland limited - inactivated salmon pancreas disease virus; inactivated infectious pancreatic necrosis virus; inactivated aeromonas salmonicida subsp. salmonicida - emulsion for injection - . - inactivated viral and inactivated bacterial vaccines - atlantic salmon - immunological - inactivated vaccine
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccines - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
fel-o-vax 3 vaccine (inactivated)
boehringer ingelheim animal health australia pty. ltd. - feline calicivirus - inactivated; feline panleucopenia virus - inactivated; feline rhinotracheitis virus - inactivated; amphotericin; neomycin; polymyxin b; thiomersal - misc. vaccines or anti sera - feline calicivirus - inactivated vaccine-viral active 0.0 ml; feline panleucopenia virus - inactivated vaccine-viral active 0.0 ml; feline rhinotracheitis virus - inactivated vaccine-viral active 0.0 ml; amphotericin antibiotic other 0.0 ml; neomycin antibiotic other 0.0 ml; polymyxin b antibiotic other 0.0 ml; thiomersal mercury other 0.0 ml - immunotherapy - cat - over 8 weeks of age - feline calicivirus | feline enteritis | feline rhinotracheitis | calicivirus (feline) | enteritis (feline) | fcv | feline herpesvirus type 1 | feline infectious enteritis | feline panleucopenia (fp) | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | panleucopenia (feline) | rhinotracheitis (feline)
fel-o-vax 5 vaccine (inactivated)
boehringer ingelheim animal health australia pty. ltd. - feline calicivirus - inactivated; chlamydophilia felis inactivated; feline leukaemia virus - inactivated; feline panleucopenia virus - inactivated; feline rhinotracheitis virus - inactivated; amphotericin; neomycin; polymyxin b; thiomersal - misc. vaccines or anti sera - feline calicivirus - inactivated vaccine-viral active 0.0 p; chlamydophilia felis inactivated vaccine-viral active 0.0 p; feline leukaemia virus - inactivated vaccine-viral active 0.0 p; feline panleucopenia virus - inactivated vaccine-viral active 0.0 p; feline rhinotracheitis virus - inactivated vaccine-viral active 0.0 p; amphotericin antibiotic other 0.32 ug/ml; neomycin antibiotic other 4.0 ug/ml; polymyxin b antibiotic other 14.0 iu/ml; thiomersal mercury other 18.0 ug/ml - immunotherapy - cat - over 8 weeks of age - feline calicivirus | feline chlamydia psittaci | feline enteritis | feline leukaemia virus | feline rhinotracheitis | calicivirus (feline) | disease caused by | enteritis (feline) | fcv | feline herpesvirus type 1 | feline infectious enteritis | feline panleucopenia (fp) | fhv-1 | fvr | herpesvirus 1 (feline) | herpesvirus type 1 (feline) | panleucopenia (feline) | rhinotracheitis (feline)
trivacton 6
merial animal health limited - inactivated bovine coronavirus strain f15, inactivated bovine rotavirus strain ro1, inactivated e.coli k99 strain serotype o101, inactivated e.coli y strain serotype o117, inactivated e.coli f41 strain serotype o101, e.coli 31a antigen - suspension for injection - unknown - inactivated bovine rotavirus vaccine + inactivated bovine coronavirus vaccine + inactivated escheri - bovine - immunological - inactivated vaccine